| Literature DB >> 30669459 |
Bihui Liu1,2,3,4, Ji Li5, Ruokun Yi6,7,8, Jianfei Mu9, Xianrong Zhou10, Xin Zhao11,12,13.
Abstract
Lotus plumule is a traditional Chinese food that can be used as a beverage. In this study, three kinds of Lotus plumules from different regions of China were selected to observe the preventive effects of extracted alkaloids on CCl₄-induced liver injuries. Animal experiments revealed that alkaloids extracted from Lotus plumules decreased the serum AST (aspartate aminotransferase), ALT (alanine aminotransferase), and TBIL (total bilirubin) levels, enhanced SOD (superoxide dismutase) activity, and reduced MDA (malondialdehyde) level in the liver tissues of mice with liver injury. H&E observation confirmed that alkaloids from Lotus plumules could alleviate CCl₄-induced injuries of liver tissues and inhibit the inflammatory effect on hepatocytes. Further qPCR experiments also demonstrated that alkaloids from Lotus plumules upregulated the expression of IκB-α (inhibitor of NF-κB alpha), Cu/Zn-SOD (copper/zinc superoxide dismutase), Mn-SOD (manganese superoxide dismutase), and CAT (catalase) mRNA and downregulated TNF-α (tumor necrosis factor alpha) and NF-κB (nuclear factor kappa B) expression in the liver tissues of mice with liver injury. All three kinds of alkaloids from Lotus plumules could prevent CCl₄-induced liver injuries by regulating the levels of oxidative stress and inflammation in mice, and the therapeutic effect was comparable to that of silymarin, the medicine commonly used in the treatment of liver diseases. In summary, alkaloids from Lotus plumules contain bioactive substances with hepatic protective efficacy and possess potential application value in the field of functional food.Entities:
Keywords: Lotus plumule; antioxidant; gene; liver injury; mice
Year: 2019 PMID: 30669459 PMCID: PMC6352077 DOI: 10.3390/foods8010036
Source DB: PubMed Journal: Foods ISSN: 2304-8158
Sequences of primers used in this study.
| Gene Name | Sequence |
|---|---|
| TNF-α | Forward: 5′-CGAGTGACAAGCCCGTAGCC-3′ |
| Reverse: 5′-GGATGAACACGCCAGTCGCC-3′ | |
| NF-κB | Forward: 5′-ATGGCAGACGATGATCCCTAC-3′ |
| Reverse: 5′-CGGAATCGAAATCCCCTCTGTT-3′ | |
| IκB-α | Forward: 5′-ATGGCAGACGATGATCCCTAC-3′ |
| Reverse: 5′-CGGAATCGAAATCCCCTCTGTT-3′ | |
| Cu/Zn-SOD | Forward: 5′-AACCAGTTGTGTTGTCAGGAC-3′ |
| Reverse: 5′-CCACCATGTTTCTTAGAGTGAGG-3′ | |
| Mn-SOD | Forward: 5′-CAGACCTGCCTTACGACTATGG-3′ |
| Reverse: 5′-CTCGGTGGCGTTGAGATTGTT-3′ | |
| CAT | Forward: 5′-GGAGGCGGGAACCCAATAG-3′ |
| Reverse: 5′-GTGTGCCATCTCGTCAGTGAA-3′ | |
| GAPDH | Forward: 5′-AGGTCGGTGTGAACGGATTTG-3′ |
| Reverse: 5′-GGGGTCGTTGATGGCAACA-3′ |
TNF-α, tumor necrosis factor α; NF-κB, nuclear factor κ -light-chain-enhancer of activated B cells; IκB-α, nuclear factor of κ-light polypeptide gene enhancer in B-cells inhibitor-α; Cu/Zn-SOD, cuprozinc-superoxide dismutase; Mn-SOD, manganese superoxide dismutase; CAT, catalase; GAPDH, glyceraldehyde-3-phosphate dehydrogenase.
Content of alkaloids extracted from Lotus plumules.
| LSA-HN | LSA-JX | LSA-HB |
|---|---|---|
| 65.3% ± 1.23 a | 66.7 ± 2.37 a | 66.2 ± 2.08 a |
a Mean values the date are not efficiently different (p > 0.05) by Duncan’s multiple range test. SA-HN, alkaloids of Lotus plumule from Hunan, China; LSA-JX, alkaloids of Lotus plumule from Jiangxi, China; LSA-HB, alkaloids of Lotus plumule from Hubei, China.
Effects of alkaloids from Lotus plumules on body weight, liver weight and liver index of mice with hepatic injury induced by carbon tetrachloride (N = 10).
| Group | Body Weight (g) | Liver Weight (g) | Liver Index |
|---|---|---|---|
| Normal | 32.00 ± 0.92 a | 1.44 ± 0.79 c | 4.5 ± 0.2 c |
| Control | 29.28 ± 1.57 a | 1.89 ± 0.96 a | 6.5 ± 0.5 a |
| Silymarin | 29.45 ± 1.53 a | 1.70 ± 0.68 b | 5.8 ± 0.4 b |
| LSA-HN | 29.29 ± 1.81 a | 1.71 ± 0.20 b | 5.8 ± 0.5 b |
| LSA-JX | 30.01 ± 1.30 a | 1.82 ± 0.15 b | 6.1 ± 0.4 b |
| LSA-HB | 29.9 ± 71.29 a | 1.80 ± 0.13 b | 6.0 ± 0.4 b |
Values presented are the mean ± standard deviation (N = 10/group). a–c Mean values with different superscript letters are significantly different (p < 0.05) by the Duncan’s multiple-range test. Silymarin, mice treated with 200 mg/kg silymarin; LSA-HN, mice treated with 400 mg/kg Lotus plumule alkaloids (Hunan, China); LSA-JX, mice treated with 400 mg/kg Lotus plumule alkaloids (Jiangxi, China); LSA-HB, mice treated with 400 mg/kg Lotus plumule alkaloids (Hubei, China).
The levels of AST, ALT and TBIL in the serum from the mice (N = 10).
| Group | AST (U/L) | ALT (U/L) | TBIL (μmol/L) |
|---|---|---|---|
| Normal | 19.32 ± 3.92 c | 29.08 ± 7.20 d | 14.93 ± 3.93 c |
| Control | 75.50 ± 4.32 a | 218.55 ± 21.28 a | 40.31 ± 0.82 a |
| Silymarin | 41.92 ± 1.21 b | 141.41 ± 13.92 c | 16.27 ± 2.41 c |
| LSA-HN | 46.06 ± 1.61 b | 174.241 ± 3.43 b | 33.97 ± 9.27 b |
| LSA-JX | 53.56 ± 7.70 b | 169.43 ± 12.59 b | 21.61 ± 2.18 b |
| LSA-HB | 43.75 ± 5.32 b | 171.64 ± 13.52 b | 31.85 ± 9.85 b |
Values presented are the mean ± standard deviation (N = 10/group). a–d Mean values with different superscript letters are significantly different (p < 0.05) by the Duncan’s multiple-range test. Silymarin, mice treated with 200 mg/kg silymarin; LSA-HN, mice treated with 400 mg/kg Lotus plumule alkaloids (Hunan, China); LSA-JX, mice treated with 400 mg/kg Lotus plumule alkaloids (Jiangxi, China); LSA-HB, mice treated with 400 mg/kg Lotus plumule alkaloids (Hubei, China).
The levels of superoxide dismutase (SOD) and malondialdehyde (MDA) in hepatic tissue of mice (N = 10).
| Group | SOD (U/mg) | MDA (nmol/mg) |
|---|---|---|
| Normal | 138.65 ± 6.58 a | 1.23 ± 0.18 d |
| Control | 52.71 ± 3.07 d | 2.69 ± 0.24 a |
| Silymarin | 108.87 ± 5.38 b | 1.66 ± 0.19 c |
| LSA-HN | 82.51 ± 4.33 c | 2.08 ± 0.16 b |
| LSA-JX | 83.06 ± 5.51 c | 1.99 ± 0.17 b |
| LSA-HB | 81.88 ± 3.10 c | 2.04 ± 0.12 b |
Values presented are the mean ± standard deviation (N=10/group). a–d Mean values with different superscript letters are significantly different (p < 0.05) by the Duncan’s multiple-range test. Silymarin, mice treated with 200 mg/kg silymarin; LSA-HN, mice treated with 400 mg/kg Lotus plumule alkaloids (Hunan, China); LSA-JX, mice treated with 400 mg/kg Lotus plumule alkaloids (Jiangxi, China); LSA-HB, mice treated with 400 mg/kg Lotus plumule alkaloids (Hubei, China).
Figure 1H & E pathological observation of liver in mice. Magnification 100×. Silymarin, mice treated with 200 mg/kg silymarin; LSA-HN, mice treated with 400 mg/kg Lotus plumule alkaloids (Hunan, China); LSA-JX, mice treated with 400 mg/kg Lotus plumule alkaloids (Jiangxi, China); LSA-HB, mice treated with 400 mg/kg Lotus plumule alkaloids (Hubei, China).
Figure 2The TNF-α, NF-κB and IκB-α mRNA expression in liver of mice. a–d Mean values with different superscript letters are significantly different (p < 0.05) by the Duncan’s multiple-range test. Silymarin, mice treated with 200 mg/kg silymarin; LSA-HN, mice treated with 400 mg/kg Lotus plumule alkaloids (Hunan, China); LSA-JX, mice treated with 400 mg/kg Lotus plumule alkaloids (Jiangxi, China); LSA-HB, mice treated with 400 mg/kg Lotus plumule alkaloids (Hubei, China).
Figure 3The Cu/Zn-SOD, Mn-SOD and CAT mRNA expression in liver of mice. a–d Mean values with different superscript letters are significantly different (p < 0.05) by the Duncan’s multiple-range test. Silymarin, mice treated with 200 mg/kg silymarin; LSA-HN, mice treated with 400 mg/kg Lotus plumule alkaloids (Hunan, China); LSA-JX, mice treated with 400 mg/kg Lotus plumule alkaloids (Jiangxi, China); LSA-HB, mice treated with 400 mg/kg Lotus plumule alkaloids (Hubei, China).